#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4495582	F	SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate	Severe acute respiratory syndrome coronavirus 2	7,212	ALA4495564	assay format	SARS-CoV-2 Screening Data 2020-21
2.	ALA4495583	F	SARS-CoV-2 3CL-Pro protease inhibition IC50 determined by FRET kind of response from peptide substrate	Severe acute respiratory syndrome coronavirus 2	109	ALA4495564	assay format	SARS-CoV-2 Screening Data 2020-21
3.	ALA4810314	B	Inhibition of SARS-CoV-2 3CLpro preincubated for 30 mins followed by addition of (Dabcyl)KTSAVLQSGFRKM(Glu) peptide substrate and measured after 1.5 hrs by FRET assay	Severe acute respiratory syndrome coronavirus 2	15	ALA4808212	single protein format	Scientific Literature
4.	ALA4810315	B	Inhibition of recombinant SARS CoV-2 main protease expressed in Escherichia coli using MCA-AVLQ SGFR-Lys (Dnp)-Lys-NH2 as substrate by FRET based assay	Severe acute respiratory syndrome coronavirus 2	2	ALA4808212	assay format	Scientific Literature
5.	ALA4810316	B	Inhibition of recombinant SARS-CoV-2 Main protease expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of DABCYL-Lys-Thr-Ser-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-Lys-Met-Glu-EDANS substrate and measured after 30 mins by microplate reader method	Severe acute respiratory syndrome coronavirus 2	2	ALA4808212	assay format	Scientific Literature
6.	ALA4810319	B	Inhibition of SARS-CoV-2 Main protease expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of Dabcyl-KTSAVLQ/SGFRKME(Edans) substrate and measured after 1 hr by FRET assay	Severe acute respiratory syndrome coronavirus 2	5	ALA4808212	assay format	Scientific Literature
7.	ALA4810320	B	Inhibition of SARS-CoV-2 3CL (3264 to 3569 residues) preincubated for 30 mins followed by addition of Dabcyl-KTSAVLQSGFRKME(Edans) substrate and measured after 1 hr by flourescence based plate reader assay	Severe acute respiratory syndrome coronavirus 2	1	ALA4808212	single protein format	Scientific Literature
8.	ALA4810322	B	Inhibition of SARS-CoV-2 3CL protease using Dabcyl-KTSAVLQSGFRKME-Edans substrate measured by flourimetric plate reader method	Severe acute respiratory syndrome coronavirus 2	1	ALA4808212	single protein format	Scientific Literature
9.	ALA4810877	B	Inhibition of SARS CoV-2 main protease using DABCYL-KTSAVLQ1SGFRKM-E(EDANS)-NH2 as substrate by FRET based assay	Severe acute respiratory syndrome coronavirus 2	21	ALA4808239	single protein format	Scientific Literature
10.	ALA4810878	B	Binding affinity to SARS CoV-2 15N/2H-labeled main protease assessed as chemical pertubations at 100 uM by 15HSQC-NMR spectrum analysis	Severe acute respiratory syndrome coronavirus 2	2	ALA4808239	single protein format	Scientific Literature
11.	ALA4810879	B	Competitive inhibition of SARS CoV-2 main protease using varying concentrations of DABCYL-KTSAVLQ1SGFRKM-E(EDANS)-NH2 as substrate by Dixon plot analysis	Severe acute respiratory syndrome coronavirus 2	1	ALA4808239	single protein format	Scientific Literature
12.	ALA4818112	B	Inhibition of SARS-CoV-2 main protease at 50 uM using Dabcy1-KTSAVLQSGFRKM-E-Edans-NH2 as substrate incubated for 10 mins followed by substrate addition by FRET assay relative to control	Severe acute respiratory syndrome coronavirus 2	17	ALA4814039	single protein format	Scientific Literature
13.	ALA4822920	B	Inhibition of SARS-CoV-2 main protease at 100 microg/ml relative to control	Severe acute respiratory syndrome coronavirus 2	3	ALA4819138	single protein format	Scientific Literature
14.	ALA4822921	B	Inhibition of SARS-CoV-2 papain-like protease at 100 microg/ml relative to control	Severe acute respiratory syndrome coronavirus 2	7	ALA4819138	single protein format	Scientific Literature
15.	ALA4822925	B	Inhibition of SARS-CoV-2 main protease	Severe acute respiratory syndrome coronavirus 2	2	ALA4819138	single protein format	Scientific Literature
16.	ALA4822926	B	Inhibition of SARS-CoV-2 papain-like protease	Severe acute respiratory syndrome coronavirus 2	2	ALA4819138	single protein format	Scientific Literature
17.	ALA4828186	B	Inhibition of SARS-CoV-2 3CLpro using TVLQ-AMC probe as substrate at 10 uM preincubated with enzyme for 5 mins followed by substrate addition and measured after 3 hrs for every 15 mins for 1 hr by FRET assay	Severe acute respiratory syndrome coronavirus 2	4	ALA4825754	single protein format	Scientific Literature
18.	ALA4828187	B	Inhibition of SARS-CoV-2 3CLpro using TVLQ-AMC probe as substrate at 50 uM preincubated with enzyme for 5 mins followed by substrate addition and measured after 3 hrs for every 15 mins for 1 hr by FRET assay	Severe acute respiratory syndrome coronavirus 2	4	ALA4825754	single protein format	Scientific Literature
19.	ALA4831799	B	Inhibition of SARS-CoV-2 RdRp transfected in human HEK293T cells cotransfected with Cov-Gluc by Gaussia luciferase reporter gene method	Severe acute respiratory syndrome coronavirus 2	28	ALA4831483	cell-based format	Scientific Literature
20.	ALA4831801	B	Inhibition of SARS-CoV-2 RdRp transfected in HEK293T cells cotransfected with CoV-Gluc assessed as decrease in plus and minus strand-Gluc RNA levels incubated for 24 hrs by qRT-PCR analysis	Severe acute respiratory syndrome coronavirus 2	6	ALA4831483	cell-based format	Scientific Literature